Quest Pharmatech Stock Market Value
| QPTFF Stock | USD 0.01 0.00 0.00% |
| Symbol | Quest |
Quest PharmaTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Quest PharmaTech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Quest PharmaTech.
| 06/15/2024 |
| 12/12/2024 |
If you would invest 0.00 in Quest PharmaTech on June 15, 2024 and sell it all today you would earn a total of 0.00 from holding Quest PharmaTech or generate 0.0% return on investment in Quest PharmaTech over 180 days. Quest PharmaTech is related to or competes with Coya Therapeutics,, Cue Biopharma, Lantern Pharma, Fennec Pharmaceuticals, Eliem Therapeutics, Trevi Therapeutics, and AN2 Therapeutics. Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer More
Quest PharmaTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Quest PharmaTech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Quest PharmaTech upside and downside potential and time the market with a certain degree of confidence.
Quest PharmaTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Quest PharmaTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Quest PharmaTech's standard deviation. In reality, there are many statistical measures that can use Quest PharmaTech historical prices to predict the future Quest PharmaTech's volatility.Quest PharmaTech Backtested Returns
We have found three technical indicators for Quest PharmaTech, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Quest PharmaTech are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Quest PharmaTech has no correlation between past and present. Overlapping area represents the amount of predictability between Quest PharmaTech time series from 15th of June 2024 to 13th of September 2024 and 13th of September 2024 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Quest PharmaTech price movement. The serial correlation of 0.0 indicates that just 0.0% of current Quest PharmaTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Quest PharmaTech lagged returns against current returns
Autocorrelation, which is Quest PharmaTech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Quest PharmaTech's pink sheet expected returns. We can calculate the autocorrelation of Quest PharmaTech returns to help us make a trade decision. For example, suppose you find that Quest PharmaTech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Quest PharmaTech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Quest PharmaTech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Quest PharmaTech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Quest PharmaTech pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Quest PharmaTech Lagged Returns
When evaluating Quest PharmaTech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Quest PharmaTech pink sheet have on its future price. Quest PharmaTech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Quest PharmaTech autocorrelation shows the relationship between Quest PharmaTech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Quest PharmaTech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Quest Pink Sheet
Quest PharmaTech financial ratios help investors to determine whether Quest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Quest with respect to the benefits of owning Quest PharmaTech security.